Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MYL6B |
| Upstream (Parents) |
|---|
| (<<) ADCY7 → MYL6B |
| (<<) CDK4 → MYL6B |
| (<<) CRYAB → MYL6B |
| (<<) E2F1 → MYL6B |
| (<<) ERBB3 → MYL6B |
| (<<) FOXA2 → MYL6B |
| (<<) FZD10 → MYL6B |
| (<<) GNAQ → MYL6B |
| (<<) GNB2L1 → MYL6B |
| (<<) IL23A → MYL6B |
| (<<) MAPK8 → MYL6B |
| (<<) NFIB → MYL6B |
| (<<) PRKCH → MYL6B |
| (<<) PRNP → MYL6B |
| (<<) SHFM1 → MYL6B |
| (<<) SLPI → MYL6B |
| (<<) UAP1 → MYL6B |
| (<<) UBE2D2 → MYL6B |
| Downstream (Children) |
|---|
| MYL6B → CRCT1 (>>) |
| MYL6B → ELF5 (>>) |
| MYL6B → MTMR6 (>>) |
| MYL6B → PAK4 (>>) |
| MYL6B → STAT5A (>>) |
| MYL6B → TIMM13 (>>) |
| MYL6B → ZFP36L1 (>>) |
